Skip to main content
PLOS One logoLink to PLOS One
. 2023 Mar 3;18(3):e0282714. doi: 10.1371/journal.pone.0282714

Association between participation in the Northern Finland Birth Cohort 1966 study and use of psychiatric care services

Martta Kerkelä 1,*, Mika Gissler 2,3,4,5, Tanja Nordström 6,7,8, Juha Veijola 1,8,9
Editor: Silva Ibrahimi10
PMCID: PMC9983849  PMID: 36867634

Abstract

Aims

In most population-based epidemiological follow-up studies the aim is not to intervene in the life of the participants. Although the idea is not to intervene, being a member of the longitudinal follow-up study and studies conducted during follow-up may affect the target population. A population-based study including mental health enquiries might reduce the unmet need for psychiatric treatment by motivating people to seek treatment for their psychiatric ill-health. We examined the use of psychiatric care services in the population born in the year 1966 in Northern Finland, of whom 96.3% are participants in the prospective Northern Finland Birth Cohort 1966 (NFBC1966).

Methods

As a study cohort we used people born in 1966 in Northern Finland (n = 11 447). The comparison cohort included all the people born in the years 1965 and 1967 in the same geographical area (n = 23 339). The follow-up period was from age 10 to 50 years. The outcome measure was the use of psychiatric care services, which was analysed using Cox Proportional Hazard regression and Zero-Truncated Negative Binomial Regression.

Results

People born in 1966 in Northern Finland did not differ from those born in 1965 and 1967 in terms of the outcome measure.

Conclusions

We found no association between participation in an epidemiological follow-up study and the use of psychiatric care services. The NFBC1966 may be regarded as a representative at the population level in terms of psychiatric outcomes despite the personal follow-up of the birth cohort. The associations of participation in epidemiological follow-up studies have previously been under-examined, and the results need to be replicated.

Introduction

Population-based follow-up studies are epidemiological studies in which a defined population is selected and followed up for longitudinal assessment of exposure-outcome relations [1]. In most population-based follow-up studies the aim is not to intervene in the life of the participants, so that the sample is a representative sample of the population. Although the idea is not to intervene, being a member of the longitudinal follow-up study and studies conducted during follow-up may affect the study population in various ways.

The awareness of participation in the study can be described as the Hawthorne effect, which describes the awareness of the study participants being studied and the possible impact on their behaviour [2]. In the Derbyshire Smoking Study, the Hawthorne effect of repeatedly measured smoking behaviour of about 6 000 adolescents was studied by questionnaire yearly from 1974 to 1978 in selected schools. The self-reported smoking habits were compared to adolescents whose smoking habits were measured first time in 1978. The findings revealed that the prevalence of smoking was lower in those schools, which had been surveyed for five years. [3]. Berkhout et al. pooled the findings of 15 studies published in 2012–2022 on the Hawthorne effect in primary care or outpatient clinics or healthy subjects. In the meta-analysis, the Hawthorne effect was defined as “an aware or unconscious complex behavioural change in a study environment, related to the interaction of four biases affecting the study subjects and investigators: selection bias, commitment and congruence bias, conformity and social desirability bias, and observation and measurement bias”. The findings demonstrate that medical research is unavoidably prone to the Hawthorne effect, which restricts its external validity, beginning with the intentional or unintentional selection of the study population, resulting in blind spots in medical knowledge [4].

Epidemiological studies have shown that there is an unmet need for psychiatric treatment in the population [5]. Various proportions of the population have been detected to have psychiatric conditions or disorders and have not been treated at all [6]. A population study including mental health enquiries might reduce the unmet need for psychiatric treatment by motivating people to seek treatment for their psychiatric ill-health. In a population-based Finnish study (the UKKI-study), the stability of and changes in mental health in the adult Finnish population was explored during 1970–1987. A population sample of the UKKI study was followed for 16 years using questionnaires, interviews, and data collection from health care registers. The possible effect of the study was examined by using controls matched to the study population. The UKKI-study participants had used mental health care services more often than the control group during the follow-up. This result may be regarded, at least partly, as an effect of the study itself [7,8].

Reviews of mental health promotion strategies, programmes and interventions have emphasised their importance for mental health, with growing evidence on their effectiveness [9]. Mental health promotion interventions are applicable to individuals and whole populations [10,11], and can be delivered in various ways, including communication technology, home-based interventions, school/workplace interventions and community-based interventions [10]. Low-level digital mental health interventions, without face-to-face interaction, are proven to improve depression, anxiety and psychological well-being among college students [12], and mental health interventions delivered via smartphone to reduce depressive symptoms in adulthood [13]. The Rural Mental Health Project in Ireland aimed to promote positive mental health in disadvantaged rural communities through information and general awareness-raising activities, community education workshops and structured positive mental health promotion programmes. The findings suggest that the project has had positive effects on community awareness and attitudes at the wider community level, including increased awareness regarding depression and suicide and improved attitudes to help-seeking [14].

We had a unique chance to examine the use of psychiatric care in the population born in 1966, of whom almost all (96.3%) participated originally in the large prospective Northern Finland Birth Cohort 1966 (NFBC1966) [15]. We examined the effects of being a member of the longitudinal follow-up study cohort compared to a population born in the same geographical area in Northern Finland in 1965 and 1967.

Materials and methods

Follow-ups of the NFBC1966

The NFBC1966 covers people whose expected date of birth was in 1966 in the former two northernmost provinces in Finland, Oulu and Lapland. The cohort included 12 055 mothers and 12 231 children. Of the NFBC1966 members, 171 (1.5%) were born in 1965, 11 999 (97.9%) in 1966 and 61 (0.5%) in 1967. NFBC1966 is a longitudinal and prospective birth cohort with several follow-ups [16]. The follow-ups were regarded as interventions in the present study.

The first follow-up for the NFBC1966 cohort was conducted during and just after the mother’s pregnancy. The follow-up included a questionnaire (including questions on background, life situation and living habits) during pregnancy (from the 24th to the 28th gestational week) collected by midwives in antenatal clinics. The questionnaire included items on depressed mood and smoking during pregnancy. Information on delivery was also collected [17]. The second follow-up was conducted at age 1 year, including a questionnaire concerning children’s growth, health, and development from children’s welfare clinics, with a 91.2% participation rate [18]. The next follow-up was at age 14 years, with a participation rate of 93.6%. The follow-up was conducted through a postal questionnaire, including questions for the NFBC 1966 members of their growth and health, living habits (questions on smoking, alcohol, and other intoxicant use), school performance and family situation [19].

The next follow-up for the whole cohort was conducted at age 31. The follow-up was done through a postal questionnaire (participation rate 77.4%), including questions on life situation, background information, exercise and physical performance, occupation, living environment, health, use of depression, tranquilliser and sleep medication, questions on possible psychiatric disorder, and living habits (questions on smoking, alcohol and other intoxicant use), and clinical examination (participation rate 71.3%) [20]. The questionnaire included The Hopkins Symptom Checklist-25 (HSCL-25) [21]. During the clinical examination, an additional questionnaire was given to the participants. The additional questionnaire included the Bipolar II scale (BIP2), Hypomanic Personality Scale (HPS), Physical Anhedonia Scale (PAS), Social Anhedonia Scale (SAS), Perceptual Aberration Scale (PER) and Schizoid Scale (SCHD) [22], Tridimensional Personality Questionnaire (TPQ) and Temperament and Character Inventory (TCI) [23].

The latest follow-up was conducted at age 46, with a 66.5% participation rate in the questionnaire and 56.7% in the clinical examination (including the cognitive Paired Associative Learning (PAL) test [24]). The questionnaire included questions on background, lifestyle (questions on smoking, alcohol, and other intoxicant use), health, economy, work, and mental resources. Depressive and anxiety symptoms were questioned using HSCL-25, the Generalized Anxiety Disorder 7-questionnaire (GAD-7) [25], Beck’s Depression Inventory 21 (BDI-21), and psychological features using the Fear-Avoidance Beliefs Questionnaire (FABQ) (Table 1).

Table 1. Follow-ups of the Northern Finland Birth Cohort 1966 (NFBC 1966).

Age (main reference) Target Population (N) Questionnaire data (Participation rate) Psychiatric items in the Questionnaires Clinical Examination (Participation rate)
Antenatal period [17] All births in the area in 1966 n = 12 527 Questionnaire to mothers from local midwives during 24th to 28th gestational week n = 12 231 (96.3%) Question of depression during pregnancy Information on delivery
1 year [18] Children alive n = 11 870 On the children’s health and development n = 10 821 (91.2%) N/A Clinical examination n = 10 821 (91.2%)
14 years [19] Children alive n = 11 778 On growth and health, hobbies, school and family situation n = 11 010 (93.6%) Questions on smoking, alcohol and other intoxicant use N/A
31 years [20] Subjects alive
n = 11 637
On background information, physical health, occupation, health and living habits n = 8 767 (75.3%) Questions on smoking, alcohol and other intoxicant use, use of mental health services and self-reported mental health problems. HSCL-25-scale. Additional questionnaire including screenings: BIP2, HPS, PAS, SAS, PER, SCHD, TPQ, TCI Clinical examination n = 6 033 (71.3%)
46 years [26] Alive and address known in Finland n = 10 321 On background information, lifestyle, economy, mental resources and health n = 6 868 (66.5%) Questions on smoking, alcohol and other intoxicant use. HSCL-25, BDI-21, GAD-7, FABQ scales, PAL-test Clinical examination n = 5 861 (56.7%), Dental clinical examination n = 1964

HSCL-25 = Hopkins Symptom Checklist-25, BIP2 = Bipolar II scale, HPS = Hypomanic Personality Scale, PAS = Physical Anhedonia Scale, SAS = Social Anhedonia Scale, PER = Perceptual Aberration Scale, SCHD = Schizoid Scale, TPQ = Tridimensional Personality Questionnaire, TCI = Temperament and Character Inventory, Beck’s Depression Inventory 21 = BDI-21, GAD-7 = Generalized Anxiety Disorder 7-questionnaire, FABQ = Fear-Avoidance Beliefs Questionnaire, PAL = Paired Associates Learning.

The NFBC1966 also contains many subsamples, of which some are focused on psychiatric outcomes. In 1997–1998, a study was conducted on people living in the city of Oulu. The sample was based on the HSCL-25 screening, which was part of a 31-year follow-up. Based on the screening, 234 screen positives (HSCL-25 scores above the mean) and every tenth screen negatives were invited to the Structured Clinical Interview for DSM-III (SCID) [27]. The SCID interview consists of two parts: SCID-I for making major DSM-III-R axis-I diagnoses and SCID-II for diagnosing all DSM-III-R personality disorders. The interview was conducted with 209 screen positives and 112 screen negatives [21]. In 1990–2001 a sub-study of individuals with psychosis and their controls was conducted. Out of the 142 invited individuals with psychosis, 91took part in the sub-study. Comparison subjects were sex-matched randomly selected from NFBC1966 members who were known not to have had a psychotic episode. A total of 187 controls were invited, and 104 subjects participated in the study [28]. The data were collected by SCID-I interview, questionnaires (including questions on use of antipsychotic medication, social background, and substance use), brain magnetic resonance imaging (MRI) scans, and cognitive tests [29]. The follow-up for the above subsample was conducted in 2008–2011, also including new subjects, 107 cases with psychotic disorders, including 54 subjects with schizophrenia, and 194 controls. The follow-up included psychiatric interviews, questionnaires, brain MRI scans, and cognitive tests [30]. In the studies conducted to individuals with psychosis and their controls, 54 cases with psychotic disorder and 76 controls participated in both sub studies. The psychiatric sub-studies and other sub-studies are presented in Table 2.

Table 2. Sub-studies of the Northern Finland Birth Cohort 1966 (NFBC1966).

Age (main reference) Target Population(N) Questionnaire data (Participation rate) Clinical Examination (Participation rate)
1 year [18] Children with perinatal risk n = 793 N/A Neurological examination n = 722 (91%)
14 years [31] Children with low school performance n = 495 N/A IQ-test
16 years [32] Unwanted children (n = 231) with control group (n = 227) Questionnaire for teachers of unwanted children n = 88 (38.1%) and controls n = 89 (39.2%) N/A
15 years [33] Children with known myopia n = 707 and their controls n = 784 N/A Ophthalmological examination of cases n = 236 (33.4%) and controls n = 266 (33.9%)
19 years [34] Twins and their controls n = 652 Questionnaire at age 19 n = 652 N/A
24 years [35] Random subsample of males n = 2500 On health and life satisfaction n = 2500 N/A
31 years [21] Living in the city of Oulu n = 1609 SCID II SCID I and SCID II interviews
31 years [36] Participated in 31-year clinical examination in the city of Oulu n = 1609 N/A Bone mineral density and content measurements n = 1102 (68.5%)
31 years [36] Random sample based on 31-years questionnaire n = 196 Exercise and food diaries for 7 days N/A
31 yearsa Subjects with problems in hearing at age of 14 and their controls n = 1372 N/A Audiogram studies
33 years [29]
Subjects with psychosis and their controls n = 191 Psychiatric interview and questionnaire Brain MRI scans and cognitive test
39 yearsa All men alive Postal questionnaire regarding loss of hair (n = 3128) N/A
42 years [29] Subjects with psychosis, their controls and siblings n = 312 Psychiatric interview and questionnaire Brain magnetic resonance imaging (MRI) scans and cognitive test
48 years [37] Random sample of the cohort was invited to eye screening n = 5155 N/A Eye screenings, n = 3070

aData has not been published.

Study and comparison cohort

The study cohort comprises all the people born in the provinces of Oulu and Lapland in 1966. In 1966 there were 12 043 births in the provinces of Lapland and Oulu, of which 96.3% are members of the NFBC1966. The comparison cohort comprises all the people born in the provinces of Lapland and Oulu in 1965 and 1967. The cohort included 24 471 subjects, 12 465 (50.9%) born in 1965 and 12 006 (49.1%) born in 1967. Personal identification numbers and date of death were obtained from the Digital and Population Data Services Agency. Medical history was obtained from the Finnish Institute of Health and Welfare (THL).

From both datasets we included in our analysis those, who were living at Finland in the beginning of follow-up at age 10. In the study cohort n = 53 (0.4%) died before their 10th birthday and n = 543 (4.5%) were living abroad at the age of 10. Respective numbers in the comparison cohort are n = 86 (0.4%) and n = 1046 (4.3%). After exclusions, 11 447 study subjects in the study cohort and 23 339 subjects in the comparison cohort were included in the analysis.

Use of psychiatric care services

We examined the use of psychiatric care services between 10th and 50th birthday using several variables. First, we created a variable indicating if the study subject had had any visit to psychiatric specialty (outpatient or inpatient). The second variable indicates if the study subject had any psychiatric hospitalization. The third variable indicates the number of days of psychiatric hospitalization of those, who had had any psychiatric hospitalization.

The variables on the use of psychiatric care services were obtained from the Care Register for Health Care (CRHC), maintained by THL. The CRHC is one of the oldest individual-level hospital discharge registers and has nationwide hospital discharge information on inpatient visits starting from 1967 (from 1969 with complete identification numbers). From 1998 onwards, the register also includes information on specialized outpatient care. By law, all hospitals are obligated to report all inpatient care. The outpatient care data covers public hospitals only.

Statistical analysis

We used several analysis methods to estimate the use of psychiatric care services between the study cohort and comparison cohort. First, we analysed the difference in any visit to any psychiatric specialty and any psychiatric hospitalization between the study and comparison cohorts using the Chi-square test. The number of days of psychiatric hospitalisation was analysed using the Mann-Whitney U-test. Age of first visit to psychiatric specialty and age of first psychiatric hospitalization was analysed using the Welch’s t-test.

Then, for the first visit to psychiatric speciality and for the first psychiatric hospitalisation, we fitted the Cox proportional hazards regression models to calculate the hazard ratios (HR) with 95% confidence intervals (CI). We also fitted the Kaplan-Meier curves and calculated the equality of survival -functions using the Log-rank-test. Time of emigration and death were used as a censoring point in analyses (information from the Population Register Centre). The number of days of psychiatric hospitalisation was analysed using the Zero-Truncated Negative Binomial Regression and incidence rate ratios (IRR) with 95% CIs are reported. Data were analysed using R software version 1.1.453.

Results

Table 3 presents the use of psychiatric care in the study and comparison cohort by sex.

Table 3. Psychiatric care service use in study and comparison cohort in males and females.

Male Female
n = 17 744 n = 17 042
Study Comparison Study Comparison
n = 5838 n = 11 906 n = 5609 n = 11 433
N (%) N (%) χ2 p N (%) N (%) χ2 p
Visit to psychiatric speciality 744 (12.7) 1434 (12.0) 1.72 0.190 727 (13.0) 1510 (13.2) 0.18 0.627
Age of first visit to psychiatric specialtya 35.14 (9.70) 35.07 (9.24) 0.15 0.875 36.90 (8.53) 37.50 (8.55) -1.58 0.116
Psychiatric hospitalisation 457 (7.8) 867 (7.3) 2.49 0.115 312 (5.6) 654 (5.6) 0.13 0.716
Age of first psychiatric hospitalisationa 31.20 (9.67) 31.14 (9.20) 0.10 0.918 32.42 (9.97) 32.33 (9.68) 0.13 0.895
Days of psychiatric hospitalisationb 28 (7.0–89.5) 31 (8–89) 1.51×105 < .001 39 (11–131) 38 (11–141.9) 7.57×104 < .001

aMean (SD), Analysed with Welch’s t-test.

bMedian (IQR), Analysed with Mann-Whitney U-statistics.

There was no difference between the study and comparison cohort in any visit to psychiatric speciality or in any psychiatric hospitalisation. Among those who had had psychiatric hospitalisation there were statistically significant results for days in psychiatric hospitalisation: males in the study cohort had a lower median number of days of psychiatric hospitalisation (study cohort median 28 days, comparison cohort median 31 days (U = 1.51×105, p < .001)), whereas females in the study cohort had a higher median number of days of psychiatric hospitalisation than the comparison cohort (study cohort median 39, comparison cohort median 38 days (U = 7.57×104, p < .001)). Age of first visit to psychiatric specialty or age of first psychiatric hospitalization did not differ between the study and comparison cohorts (Table 3).

Table 4 presents the results of the Zero Truncated Negative Binomial Regression and Cox Proportional Hazard regression. No difference was found in the use of psychiatric care services between the study and comparison.

Table 4. Results of comparison between study and comparison cohorts analysed with Cox Proportional Hazard model (HR) and Zero-Truncated Negative Binomial regression (IRR) with 95% CI. by sex.

The comparison cohort is the reference group in all models.

Male Female
(n = 17 744) (n = 17 042)
HR 95% CI p HR 95% CI p
First visit to psychiatric specialty
Study cohort 1.05 0.96–1.15 0.244 0.98 0.90–1.07 0.672
Hospitalization in a psychiatric specialty
Study cohort 1.09 0.97–1.22 0.133 1.03 0.90–1.17 0.705
IRR 95% CI p IRR 95% CI p
Days of psychiatric hospitalization
Study cohort 0.92 0.74–1.17 0.530 0.86 0.68–1.10 0.231

The results of the Kaplan-Meier survival curves are presented in Figs 1 and 2.

Fig 1. Kaplan-Meier curve for first visit to psychiatric specialty for study and comparison cohorts by sex with p-value from log-rank test.

Fig 1

Fig 2. Kaplan-Meier curve for first psychiatric hospitalization for study and comparison cohorts by sex with p-value from log-rank test.

Fig 2

The survival curves for first visit to psychiatric speciality (Fig 1) or first psychiatric hospitalisation (Fig 2) between the study and comparison cohorts did not differ.

Discussion

No evidence of an association of being a member of a longitudinal follow-up study and studies conducted during follow-up to a use of psychiatric care services was found. There was a significant result on the median number of days of psychiatric hospitalisation, but when analysed further with the Zero-Truncated Binomial Regression, the significance diminished. The results indicate that even a long follow-up with many follow-ups does not necessarily affect participants’ life or behaviour, at least in the use of psychiatric care service. Of those 12.7% who visited psychiatric specialty, the mean ages of first visit for psychiatric specialty were between 35 and 37 years and of those 6.7% who had psychiatric hospitalization, mean ages of first psychiatric hospitalizations were between 31 and 32 years in the study cohort. The follow-ups for whole cohort including psychiatric screens were conducted at age 31 and 46, and the sub-studies focusing on psychiatric measurements at age 33 and 42. The associations of participation in an epidemiological follow-up study are rarely studied, and the results need to be replicated. The NFBC1966 may be regarded as representative at the population level in terms of psychiatric outcomes despite the personal follow-up of the birth cohort.

The participation rate in the follow-up studies decreased from 91.2% in the 1-year study, 93.6% in the 14-year study, 77.4% in the 31-year study to 66.5% in the 46-year study. It is already known that participants of the NFBC1966 in the 31-year and 46-year studies are more often female, were less often unemployed and are from higher social class [26] and subjects with psychiatric disorders participated less actively than those without any psychiatric disorders in the 31-year study [38]. The selective non-participation bias does exist in the NFBC1966. However, as the aim of the study was to examine the effects of participation in the longitudinal follow-up study, and the postal follow-up questionnaires have been sent to N = 11,870 (97.0% of original cohort members) at 1-year follow-up, N = 11,768 (96.2%) at 14-year follow-up, N = 11,543 (94.4%) at 31-year follow-up and N = 10,331 (83.8%) at age of 46-years, the vast majority of members of NFBC1966 have been aware of longitudinal follow-up.

A previous study did find an association between the Northern Finland Birth Cohort 1986 (NFBC1986) and mental disorders; the female members of the NFBC1986 had less psychiatric diagnoses at age 2 to 28 years than the comparison cohort [39]. Both of the NFBC studies are prospective longitudinal birth cohorts with multiple follow-ups. Even though both cohorts have been followed since birth, in the NFBC1986 the follow-up has been more intense in childhood and adolescence (follow-ups for the whole cohort at age 7, 8 and 15–16), while in the NFBC1966 there was data collection only at age 14 with a questionnaire. The difference in follow-ups might explain the contradictive results in the studies.

The UKKI-study, in which the study participants had used mental health care services more often than the control group, was a long follow-up psychiatric study aiming to find people with psychiatric disorders using psychiatric interviews [8]. Compared to the UKKI study the NFBC1966 did not focus on psychiatric outcomes but covered all aspects of health-related issues. In the NFBC1966 only a minority of the participants were interviewed using psychiatric methods. In the psychiatric UKKI-study, participants were interviewed twice, which might have reduced the unmet need for psychiatric treatment by motivating people to seek treatment for their psychiatric ill-health [5,6].

Strengths

To our knowledge, the associations of participation in a prospective epidemiological study are rarely studied. The size of the study population was relatively large, and the follow-up covered 40 years. The data used in this study were from the Finnish Care Register for Health Care, which has been found to have a good standard [40].

The participation rate in the NFBC1966 can be considered somewhat high in the oldest follow-ups (93.6% in the 14-year follow-up and 77.4% in the 31-year follow-up), which makes the study setting even stronger. Nowadays there is an issue of poor response rates in follow-up population cohort studies [41].

Limitations

The study also has some limitations. We could not identify those in our study cohort who really participated in the NFBC1966 and took part to follow-up studies. Nevertheless, 96.3% of our study cohort was originally a member of the NFBC1966. Even though the follow-up in NFBC includes many questionnaires and clinical examinations, only few of them were focused on psychiatric measurements. Also, we did not have the information of possible family members in the study and comparison cohorts. The health care use of a family member may affect other family members.

Conclusions

We found no evidence of an association between participation in an epidemiological follow-up study and the use of psychiatric care services. The Northern Finland Birth Cohort 1966 may be regarded as representative at the population level in terms of psychiatric outcomes despite the personal follow-up of the birth cohort. The effects of participation in epidemiological follow-up studies have previously been under-examined, and the results need to be replicated. In addition, the use of psychiatric medications might prove an important area for future research. The follow-up studies conducted among the participants might be considered as interventions.

Acknowledgments

We thank all cohort members and researchers who participated in the Northern Finland Birth cohort 1966 study. We also wish to acknowledge the work of the NFBC project center.

Data Availability

Data cannot be shared publicly because the utilised data have been given for this specific study (Permission numbers: TK-53-1053-19, VRK/3285/2019-2, THL/1254/2019), and the data cannot be shared without permission from the register keepers. The same data can be applied from Findata, the Finnish Health and Social Data Permit Authority by researchers who meet the criteria for access to confidential data. Additionally, Findata, can prepare statistical tables from the registers used in this study: https://findata.fi/en/permits/data-requests/.

Funding Statement

The author(s) received no specific funding for this work.

References

  • 1.Szklo M. Population-based Cohort Studies. Epidemiol Rev. 1998;20: 81–90. doi: 10.1093/oxfordjournals.epirev.a017974 [DOI] [PubMed] [Google Scholar]
  • 2.Jones SRG. Was There a Hawthorne Effect? American Journal of Sociology. 1992;98: 451–468. doi: 10.1086/230046 [DOI] [Google Scholar]
  • 3.Murray M, Swan AV., Kiryluk S, Clarke GC. The Hawthorne effect in the measurement of adolescent smoking. J Epidemiol Community Health (1978). 1988;42. doi: 10.1136/jech.42.3.304 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Berkhout C, Berbra O, Favre J, Collins C, Calafiore M, Peremans L, et al. Defining and evaluating the Hawthorne effect in primary care, a systematic review and meta-analysis. Front Med (Lausanne). 2022;9. doi: 10.3389/fmed.2022.1033486 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Roberts T, Miguel Esponda G, Krupchanka D, Shidhaye R, Patel V, Rathod S. Factors associated with health service utilisation for common mental disorders: a systematic review. BMC Psychiatry. 2018;18: 262. doi: 10.1186/s12888-018-1837-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Bijl RV, de Graaf R, Hiripi E, Kessler RC, Kohn R, Offord DR, et al. The Prevalence Of Treated And Untreated Mental Disorders In Five Countries. Health Aff. 2003;22: 122–133. doi: 10.1377/hlthaff.22.3.122 [DOI] [PubMed] [Google Scholar]
  • 7.Lehtinen V, Lindholm T, Veijola J, Väisänen E, Puukka P. Stability of prevalences of mental disorders in a normal population cohort followed for 16 years. Soc Psychiatry Psychiatr Epidemiol. 1991;26: 40–46. doi: 10.1007/BF00783580 [DOI] [PubMed] [Google Scholar]
  • 8.Lehtinen V, Veijola J, Lindohlm T, Väisänen E, Moring J, Puukka P. Stability and changes of mental health in the adult Finnish population. Main results from the 16-year follow-up of the UKKI-study. Turku: Publications of the Social Insurance Institution, Finland. AL: 36, 1993;375:294. [Google Scholar]
  • 9.Jané-Llopis E, Barry M, Hosman C, Patel V. Mental health promotion works: a review. Promot Educ. 2005;12: 9–25. doi: 10.1177/10253823050120020103x [DOI] [PubMed] [Google Scholar]
  • 10.Sharma A, Sharma SD, Sharma M. Mental health promotion: a narrative review of emerging trends. Current Opinion in Psychiatry. 2017;30;339–345. doi: 10.1097/YCO.0000000000000347 [DOI] [PubMed] [Google Scholar]
  • 11.Pollett H. Mental health promotion: A literature review. Ottawa, Ontario: Canadian Mental Health Association. 2007;29: 2009. [Google Scholar]
  • 12.Lattie EG, Adkins EC, Winquist N, Stiles-Shields C, Wafford QE, Graham AK. Digital Mental Health Interventions for Depression, Anxiety, and Enhancement of Psychological Well-Being Among College Students: Systematic Review. J Med Internet Res. 2019;21: e12869. doi: 10.2196/12869 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Firth J, Torous J, Nicholas J, Carney R, Pratap A, Rosenbaum S, et al. The efficacy of smartphone-based mental health interventions for depressive symptoms: a meta-analysis of randomized controlled trials. World Psychiatry. 2017;16: 287–298. doi: 10.1002/wps.20472 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Reynolds C, Byrne M, Barry M. Final Evaluation Report of the Rural Mental Health Project (Phase 2). Centre for Health Promotion Studies, National University of Ireland. 2004. [Google Scholar]
  • 15.University of Oulu: Northern Finland Birth Cohort 1966. University of Oulu. [Cited 2022 March 19] In: http://urn.fi/urn:nbn:fi:att:bc1e5408-980e-4a62-b899-43bec3755243.
  • 16.Rantakallio P. The longitudinal study of the northern Finland birth cohort of 1966. Paediatr Perinat Epidemiol. 1988;2: 59–88. doi: 10.1111/j.1365-3016.1988.tb00180.x [DOI] [PubMed] [Google Scholar]
  • 17.Järvelin MR, Hartikainen-Sorri AL, Rantakallio P. Labour induction policy in hospitals of different levels of specialisation. Br J Obstet Gynaecol. 1993;100: 310–315. doi: 10.1111/j.1471-0528.1993.tb12971.x [DOI] [PubMed] [Google Scholar]
  • 18.von Wendt L, Mäkinen H, Rantakallio P. Psychomotor development in the first year and mental retardation—a prospective study. J Ment Defic Res. 1984;28 (Pt 3): 219–225. doi: 10.1111/j.1365-2788.1984.tb01013.x [DOI] [PubMed] [Google Scholar]
  • 19.Rantakallio P. A Follow-up study up to the age of 14 of children whose mothers smoked during pregnancy. Acta Paediatrica. 1983;72: 747–753. doi: 10.1111/j.1651-2227.1983.tb09805.x [DOI] [PubMed] [Google Scholar]
  • 20.Järvelin MR, Sovio U, King V, Lauren L, Xu B, McCarthy MI, et al. Early Life Factors and Blood Pressure at Age 31 Years in the 1966 Northern Finland Birth Cohort. Hypertension. 2004;44: 838–846. doi: 10.1161/01.HYP.0000148304.33869.ee [DOI] [PubMed] [Google Scholar]
  • 21.Veijola J, Jokelainen J, Läksy K, Kantojärvi L, Kokkonen P, Järvelin MR, et al. The Hopkins Symptom Checklist-25 in screening DSM-III-R axis-I disorders. Nord J Psychiatry. 2003;57: 119–123. doi: 10.1080/08039480310000941 [DOI] [PubMed] [Google Scholar]
  • 22.Miettunen J, Veijola J, Freimer N, Lichtermann D, Peltonen L, Paunio T, et al. Data on schizotypy and affective scales are gender and education dependent—Study in the Northern Finland 1966 Birth Cohort. Psychiatry Res. 2010;178: 408–413. doi: 10.1016/j.psychres.2008.07.022 [DOI] [PubMed] [Google Scholar]
  • 23.Miettunen J, Kantojärvi L, Ekelund J, Veijola J, Karvonen JT, Peltonen L, et al. A large population cohort provides normative data for investigation of temperament. Acta Psychiatrica Scandinavica. 2004;110: 150–157. doi: 10.1111/j.1600-0047.2004.00344.x [DOI] [PubMed] [Google Scholar]
  • 24.Taivalantti M, Barnett JH, Halt A-H, Koskela J, Auvinen J, Timonen M, et al. Depressive symptoms as predictors of visual memory deficits in middle-age. J Affect Disord. 2020;264: 29–34. doi: 10.1016/j.jad.2019.11.125 [DOI] [PubMed] [Google Scholar]
  • 25.Kujanpää TS, Jokelainen J, Auvinen JP, Timonen MJ. The association of generalized anxiety disorder and Somatic Symptoms with frequent attendance to health care services: A cross-sectional study from the Northern Finland Birth Cohort 1966. Int J Psychiatry Med. 2017;52: 147–159. doi: 10.1177/0091217417720894 [DOI] [PubMed] [Google Scholar]
  • 26.Nordström T, Miettunen J, Auvinen J, Ala-Mursula L, Keinänen-Kiukaanniemi S, Veijola J, et al. Cohort Profile: 46 years of follow-up of the Northern Finland Birth Cohort 1966 (NFBC1966). Int J Epidemiol. 2021; dyab109. doi: 10.1093/ije/dyab109 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Spitzer RL, Williams JB, Gibbon M, First MB. The Structured Clinical Interview for DSM-III-R (SCID). I: History, rationale, and description. Arch Gen Psychiatry. 1992;49: 624–629. doi: 10.1001/archpsyc.1992.01820080032005 [DOI] [PubMed] [Google Scholar]
  • 28.Tanskanen P, Veijola JM, Piippo UK, Haapea M, Miettunen JA, Pyhtinen J, et al. Hippocampus and amygdala volumes in schizophrenia and other psychoses in the Northern Finland 1966 birth cohort. Schizophr Res. 2005;75: 283–294. doi: 10.1016/j.schres.2004.09.022 [DOI] [PubMed] [Google Scholar]
  • 29.Haapea M, Miettunen J, Veijola J, Lauronen E, Tanskanen P, Isohanni M. Non-participation may bias the results of a psychiatric survey: an analysis from the survey including magnetic resonance imaging within the Northern Finland 1966 Birth Cohort. Soc Psychiatry Psychiatr Epidemiol. 2007;42: 403–409. doi: 10.1007/s00127-007-0178-z [DOI] [PubMed] [Google Scholar]
  • 30.Jääskeläinen E, Haapea M, Rautio N, Juola P, Penttilä M, Nordström T, et al. Twenty Years of Schizophrenia Research in the Northern Finland Birth Cohort 1966: A Systematic Review. Schnack, editor. Schizophr Res Treatment. 2015;2015: 524875. doi: 10.1155/2015/524875 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Rantakallio P, von Wendt L. Mental retardation and subnormality in a birth cohort of 12,000 children in Northern Finland. Am J Ment Defic. 1986;90: 380–387. [PubMed] [Google Scholar]
  • 32.Myhrman A. Family relation and social competence of children unwanted at birth. A follow-up study at the age of 16. Acta Psychiatr Scand. 1988;77: 181–187. doi: 10.1111/j.1600-0447.1988.tb05098.x [DOI] [PubMed] [Google Scholar]
  • 33.Krause UH, Rantakallio PT, Koiranen MJ, Möttönen JK. The development of myopia up to the age of twenty and a comparison of refraction in parents and children. Arctic Med Res. 1993;52: 161–165. [PubMed] [Google Scholar]
  • 34.Moilanen I, Rantakallio P. The growth, development and education of Finnish twins: a longitudinal follow-up study in a birth cohort from pregnancy to nineteen years of age. Growth Dev Aging. 1989;53: 145–150. [PubMed] [Google Scholar]
  • 35.Pietilä A-M. Life control and health. A longitudinal study on Northern Finnish young men. Acta Universitatis Ouluensis, Series D, Medica, ISSN 0355-3221;1994:313. [Google Scholar]
  • 36.Laitinen J, Kiukaanniemi K, Heikkinen J, Koiranen M, Nieminen P, Sovio U, et al. Body size from birth to adulthood and bone mineral content and density at 31 years of age: results from the northern Finland 1966 birth cohort study. Osteoporosis International. 2005;16: 1417–1424. doi: 10.1007/s00198-005-1857-9 [DOI] [PubMed] [Google Scholar]
  • 37.Saarela V, Karvonen E, Stoor K, Hägg P, Luodonpää M, Kuoppala J, et al. The Northern Finland Birth Cohort Eye Study: Design and baseline characteristics. BMC Ophthalmol. 2013;13: 51. doi: 10.1186/1471-2415-13-51 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Haapea M, Miettunen J, Isohanni MK, Veijola JM, Läärä E, Järvelin MR, et al. Non-participation in a field survey with respect to psychiatric disorders. Scand J Public Health. 2008;36. doi: 10.1177/1403494808092250 [DOI] [PubMed] [Google Scholar]
  • 39.Kerkelä M, Gissler M, Veijola J. Association of participation in the Northern Finland Birth Cohort 1986 with mental disorders and suicidal behaviour. Epidemiol Health. 2022;44:e2022005. doi: 10.4178/epih.e2022005 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Sund R. Quality of the Finnish Hospital Discharge Register: a systematic review. Scand J Public Health. 2012;40: 505–515. doi: 10.1177/1403494812456637 [DOI] [PubMed] [Google Scholar]
  • 41.Galea S, Tracy M. Participation rates in epidemiologic studies. Ann Epidemiol. 2007;17: 643–653. doi: 10.1016/j.annepidem.2007.03.013 [DOI] [PubMed] [Google Scholar]

Decision Letter 0

Jamie Males

2 Sep 2022

PONE-D-22-16407Association between participation to the Northern Finland Birth Cohort 1966 study and use of psychiatric care servicesPLOS ONE

Dear Dr. Kerkelae,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

 Two external reviewers have evaluated your submission. Both were positive about the manuscript, but Reviewer 1 has made some suggestions for improvement that we would ask you to consider and respond to. Please attend carefully to each of the points they have raised when preparing your revision.

Please submit your revised manuscript by Oct 17 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Jamie Males

Editorial Office

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. In your Data Availability statement, you have not specified where the minimal data set underlying the results described in your manuscript can be found. PLOS defines a study's minimal data set as the underlying data used to reach the conclusions drawn in the manuscript and any additional data required to replicate the reported study findings in their entirety. All PLOS journals require that the minimal data set be made fully available. For more information about our data policy, please see http://journals.plos.org/plosone/s/data-availability.

Upon re-submitting your revised manuscript, please upload your study’s minimal underlying data set as either Supporting Information files or to a stable, public repository and include the relevant URLs, DOIs, or accession numbers within your revised cover letter. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. Any potentially identifying patient information must be fully anonymized.

Important: If there are ethical or legal restrictions to sharing your data publicly, please explain these restrictions in detail. Please see our guidelines for more information on what we consider unacceptable restrictions to publicly sharing data: http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. Note that it is not acceptable for the authors to be the sole named individuals responsible for ensuring data access.

We will update your Data Availability statement to reflect the information you provide in your cover letter.

3. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: No

Reviewer #2: No

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: No

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The study by Dr. Kerkelae and colleagues aimed to examine whether the use of psychiatric care services differed between individuals included in the Northern Finland Birth Cohort 1966 (NFBC1966) and individuals born in 1965 and 1967. The authors found no evidence of a difference in psychiatric outcomes, suggesting that the NFBC1966 may represent the population. The results may be relevant for future research using the NFBC1966 cohort. I have a few suggestions/comments the authors may wish to consider:

1. Table 3: Suggest presenting the results in the form of N (%)

2. How many comparison individuals born in 1965 and 1967 are family members (siblings or a spouse) of individuals in the NFBC1966 cohort? The visit of a family member may affect their health service use and thus dilute the impact of the cohort effect.

3. As the authors discussed in the limitation section, only a few follow-ups focused on psychiatric measurements at ages 33 and 42 years. What was the mean (SD) age of first psychiatric hospital contact? Suppose the first visit to a psychiatric specialty occurred before these follow-ups. In that case, it is less likely affected by the follow-up.

4. The authors studied severe psychiatric outcomes, such as psychiatric specialty visits and hospitalizations. However, it is relevant to know whether the patterns of prescription filling for psychiatric medications differ between individuals in the NFBC1966 and individuals born in 1965 or 1967.

Reviewer #2: Thank you for letting me review this article. I suggest accept. I believe this submission will contribute to fill the gap in knowledge in whether how much questionnaires in research intervene in the health care seeking patterns.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2023 Mar 3;18(3):e0282714. doi: 10.1371/journal.pone.0282714.r002

Author response to Decision Letter 0


26 Sep 2022

Comments by the Academic Editor:

Editor E1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

Response E1. We have now revised our manuscript and restyled the manuscript and files.

Editor E2. In your Data Availability statement, you have not specified where the minimal data set underlying the results described in your manuscript can be found. PLOS defines a study's minimal data set as the underlying data used to reach the conclusions drawn in the manuscript and any additional data required to replicate the reported study findings in their entirety. All PLOS journals require that the minimal data set be made fully available. For more information about our data policy, please see http://journals.plos.org/plosone/s/data-availability.

Upon re-submitting your revised manuscript, please upload your study’s minimal underlying data set as either Supporting Information files or to a stable, public repository and include the relevant URLs, DOIs, or accession numbers within your revised cover letter. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. Any potentially identifying patient information must be fully anonymized.

Important: If there are ethical or legal restrictions to sharing your data publicly, please explain these restrictions in detail. Please see our guidelines for more information on what we consider unacceptable restrictions to publicly sharing data: http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. Note that it is not acceptable for the authors to be the sole named individuals responsible for ensuring data access.

We will update your Data Availability statement to reflect the information you provide in your cover letter.

Response E2: We have now modified the Data Availability Statement:

‘Data cannot be shared publicly because the utilised data have been given for this specific study (Permission numbers: TK-53-1053-19, VRK/3285/2019-2, THL/1254/2019), and the data cannot be shared without permission from the register keepers. The same data can be applied from Findata, the Finnish Health and Social Data Permit Authority by researchers who meet the criteria for access to confidential data. Additionally, Findata, can prepare statistical tables from the registers used in this study:

https://findata.fi/en/permits/data-requests/’

Editor E3. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

Response E3: We revised the reference list (we did not identify any retracted references) and made corrections to the references: ref 7 and ref 28 (added the doi), ref 18, ref 20, ref 30 (corrected the doi) and corrected the title of the reference 32.

 

Comments by the Rewievers

Reviewer #1

Reviewer R1.1: The study by Dr. Kerkelä and colleagues aimed to examine whether the use of psychiatric care services differed between individuals included in the Northern Finland Birth Cohort 1966 (NFBC1966) and individuals born in 1965 and 1967. The authors found no evidence of a difference in psychiatric outcomes, suggesting that the NFBC1966 may represent the population. The results may be relevant for future research using the NFBC1966 cohort.

Response R1.1: Thank you for this comment.

Reviewer R1.1: Table 3: Suggest presenting the results in the form of N (%)

Response R1.1: We have now modified the table and report the results in the form of N (%).

Reviewer R1.2. How many comparison individuals born in 1965 and 1967 are family members (siblings or a spouse) of individuals in the NFBC1966 cohort? The visit of a family member may affect their health service use and thus dilute the impact of the cohort effect.

Response R1.2: Unfortunately, we do not have data of family members. We agree that this is a potential limitation of the study, and added the information in the limitations section:

‘Also, we did not have the information of possible family members in the study and comparison cohorts. The health care use of a family member may affect other family members.’.

Reviewer R1.3. As the authors discussed in the limitation section, only a few follow-ups focused on psychiatric measurements at ages 33 and 42 years. What was the mean (SD) age of first psychiatric hospital contact? Suppose the first visit to a psychiatric specialty occurred before these follow-ups. In that case, it is less likely affected by the follow-up.

Response R1.3: We added the mean ages with SDs and the comparison with the Welch's t-test of the age of first visit to psychiatric specialty and first psychiatric hospitalisation to the table 3 and edited the legend of the table:

‘Psychiatric care service use in study and comparison cohort in males and females.’

The new analysis is mentioned in the 2.4 Statistical analysis section:

‘Age of first visit to psychiatric specialty and age of first psychiatric hospitalization was analysed using the Welch's t-test’

and in the 3. Results section the new comparison was mentioned:

‘Age of first visit to psychiatric specialty or age of first psychiatric hospitalization did not differ between the study and comparison cohorts.’

In the 4. discussion section the mean ages are mentioned:

‘Of those 12.7% who visited psychiatric specialty, the mean ages of first visit for psychiatric specialty were between 35 and 37 years and of those 6.7% who had psychiatric hospitalization, mean ages of first psychiatric hospitalizations were between 31 and 32 years in the study cohort. The follow-ups for whole cohort including psychiatric screens were conducted at age 31 and 46, and the sub-studies focusing on psychiatric measurements at age 33 and 42. ´

Reviewer R1.4. The authors studied severe psychiatric outcomes, such as psychiatric specialty visits and hospitalizations. However, it is relevant to know whether the patterns of prescription filling for psychiatric medications differ between individuals in the NFBC1966 and individuals born in 1965 or 1967.

Response R1.4: We agree with the reviewer that further elaborating on this point would be important. Unfortunately, we do not have data of the medications, since the registration in Finland was started in 1994 (reimbursed medication) and it was not complete before 2017 (prescribed medication). We have added the potential future research in the conclusion:

‘The effects of participation in epidemiological follow-up studies have previously been under-examined earlier, and the results need to be replicated. In addition, the use of psychiatric medications might prove an important area for future research.’

Reviewer R2: Thank you for letting me review this article. I suggest accept. I believe this submission will contribute to fill the gap in knowledge in whether how much questionnaires in research intervene in the health care seeking patterns.

Response R2: We appreciate the Reviewer’s input to review the manuscript and give this positive comment. The manuscript has now been proofread, and the typographical and grammatical errors have been corrected as you suggested.

Additional edits:

A1. The manuscript has been proofread by a professional.

Attachment

Submitted filename: Response to Reviewers.docx

Decision Letter 1

Silva Ibrahimi

28 Nov 2022

PONE-D-22-16407R1Association between participation in the Northern Finland Birth Cohort 1966 study and use of psychiatric care servicesPLOS ONE

Dear Dr. Kerkelae,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

In merit  to your significant work and respecting the concerns raised by the third reviewer,I would like to invite your attention on  a few points:1. Please clarify if there might be any bias or interpretation between the association of participation of psychiatric patients and non-participants in the study.2. Please give an an explanation or write a paragraph that could explain if there emerge any difference when the comparison cohort study is conducted  with a   reduced sample. Please pay attention to the reviewers' comments and suggestions, and re-submit a revised until Jan 12 2023 11:59PM, so we will manage to review it with the proposed changes at the soonest.  If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

We look forward to receiving your revised manuscript.

Kind regards,

Dr. Silva Ibrahimi, PhD

Academic Editor

PLOS ONE

Journal Requirements:

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #2: All comments have been addressed

Reviewer #3: (No Response)

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research  data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #2: Yes

Reviewer #3: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #2: Yes

Reviewer #3: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #2: No

Reviewer #3: No

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #2: Yes

Reviewer #3: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #2: (No Response)

Reviewer #3: In this study, the authors examined whether use of psychiatric care services differed between individuals included in the Northern Finland Birth Cohort 1966 (NFBC1966) differed from individuals born in 1965 and 1967, their hypothesis being that study involvement may act as an intervention of sorts by motivating people to seek treatment they otherwise would not. The authors found no evidence of a difference in psychiatric outcomes, suggesting NFBC1966 is representative of the broader population. I think this could be valuable information for those using this data resource in the future. However, I have a couple of things I would like to see the authors address first...

1. The authors' characterization of potential inks between participation and health implies that participation may cause improvement in health. This seems a little odd to me, typically associations between participation and health are interpreted through the lens of selection bias - unhealthy people are less likely to take part in studies and more likely to drop out when they do. This doesn't actually impact the value of the research, but the authors should acknowledge that where associations are detected elsewhere this is often the interpretation.

2. Analyses all compare the full 1966 cohort to the combined 1965/67 cohort. However, the 1966 cohort actually diminishes over time, as reduced numbers take part at age 1, 14, 31, and 46. Can the authors compare the reduced samples to the comparison cohort to see if differences emerge over time? This again speaks to the fact that differences between participants and non-participants are typically interpreted as selection bias, rather than evidence for positive effects of the study's participation. e.g. The authors hypothesize that study participation will increase use of psychiatric services, so the 1966 cohort will use more that the 65/67 cohort. They find no evidence for this. Would their hypothesis apply to the samples reduced by attrition? i.e. if participation increases service use then would continued participation predict service use? This would run counter to a hypothesis that selection bias would mean that service use would predict drop out. Could the authors run such analyses to test these contrasting hypotheses?

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #2: No

Reviewer #3: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2023 Mar 3;18(3):e0282714. doi: 10.1371/journal.pone.0282714.r004

Author response to Decision Letter 1


20 Dec 2022

Comments by the Academic Editor:

Editor E1: Please clarify if there might be any bias or interpretation between the association of participation of psychiatric patients and non-participants in the study.

Response E1: We are aware of selective non-participation bias in the NFBC1966. It is already known that participants of the NFBC1966 in the 31-year and 46-year studies are more often female, were less often unemployed and are from higher social class (Nordström T, Miettunen J, Auvinen J et al., 2021) and subjects with psychiatric disorders participated less actively than those without any psychiatric disorders in the 31-year study (Haapea M, Miettunen J, Läärä E, et al. 2008). But, in the present study we did not actually focus on the attrition of the NFBC1966 sample, but more in the effects of the longitudinal follow-up study, nevertheless have the subject participated in each follow-up study or not. Please see response R3.3.

References:

Nordström T, Miettunen J, Auvinen J, Ala-Mursula L, Keinänen-Kiukaanniemi S, Veijola J, et al. Cohort Profile: 46 years of follow-up of the Northern Finland Birth Cohort 1966 (NFBC1966). Int J Epidemiol. 2021; dyab109. doi:10.1093/ije/dyab109

Haapea M, Miettunen J, Isohanni MK, Veijola JM, Läärä E, Järvelin MR, et al. Non-participation in a field survey with respect to psychiatric disorders. Scand J Public Health. 2008;36. doi:10.1177/1403494808092250

Editor E2: Please give an an explanation or write a paragraph that could explain if there emerge any difference when the comparison cohort study is conducted with a reduced sample.

Response E2: The study group was not NFBC1966 per se, but a population born in 1966 in Northern Finland. We could not identify those who participated in the NFBC1966 and took part in follow-up studies. Nevertheless, 96.3% of the study cohort were members of the NFBC1966. Please see response R3.3

Journal Requirements JR1: Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

Response JR1: We have now revised the reference list and corrected the reference 20: Järvelin MR, Sovio U, King V, Lauren L, Xu B, McCarthy MI, Hartikainen AL, Laitinen J, Zitting P, Rantakallio P, Elliott P. Early Life Factors and Blood Pressure at Age 31 Years in the 1966 Northern Finland Birth Cohort. Hypertension. 2004;44: 838–846. doi:10.1161/01.HYP.0000148304.33869.ee

Reviewer R3.1: In this study, the authors examined whether use of psychiatric care services differed between individuals included in the Northern Finland Birth Cohort 1966 (NFBC1966) differed from individuals born in 1965 and 1967, their hypothesis being that study involvement may act as an intervention of sorts by motivating people to seek treatment they otherwise would not. The authors found no evidence of a difference in psychiatric outcomes, suggesting NFBC1966 is representative of the broader population. I think this could be valuable information for those using this data resource in the future. However, I have a couple of things I would like to see the authors address first...

Response R3.1: Thank you for the comment.

Reviewer R3.2: The authors' characterization of potential inks between participation and health implies that participation may cause improvement in health. This seems a little odd to me, typically associations between participation and health are interpreted through the lens of selection bias - unhealthy people are less likely to take part in studies and more likely to drop out when they do. This doesn't actually impact the value of the research, but the authors should acknowledge that where associations are detected elsewhere this is often the interpretation.

Response R3.2 The reviewer is right, the selection bias exists in the NFBC1966 (Please see a more detailed answer for attrition and biases in Response R3.3). We were focused on the effects of being a member of the longitudinal follow-up study, more than attrition. We modified the aims of the study:

‘We examined the effects of being a member of the longitudinal follow-up study cohort compared to a population born in the same geographical area in Northern Finland in 1965 and 1967.’

edited the abstract: ‘Although the idea is not to intervene, being a member of the longitudinal follow-up study and studies conducted during follow-up may affect the target population. ‘

introduction: ‘Although the idea is not to intervene, being a member of the longitudinal follow-up study and studies conducted during follow-up may affect the study population in various ways.’

also we added achapter on the effects of awareness of participation in the study in the introduction section to emphasize the aims of the study:

‘The awareness of participation in the study can be described as the Hawthorne effect, which describes the awareness of the study participants being studied and the possible impact on their beaviour. (Jones, 1992) In the Derbyshire Smoking Study, the Hawthorne effect of repeatedly measured smoking behaviour of about 6000 adolescents was studied by questionnaire yearly from 1974 to 1978 in selected schools. The self-reported smoking habits were compared to adolescents whose smoking habits were measured first time in 1978. The findings revealed that the prevalence of smoking was lower in those schools, which had been surveyed for five years. (Murray et al., 1988). Berkhout et all. pooled the findings of 15 studies published in 2012-2022 on the Hawthorne effect in primary care or outpatient clinics or healthy subjects. In the meta-analysis, the Hawthorne effect was defined as “an aware or unconscious complex behavioural change in a study environment, related to the interaction of four biases affecting the study subjects and investigators: selection bias, commitment and congruence bias, conformity and social desirability bias, and observation and measurement bias”. The findings demonstrate that medical research is unavoidably prone to the Hawthorne effect, which restricts its external validity, beginning with the intentional or unintentional selection of the study population, resulting in blind spots in medical knowledge. (Berkhout et al., 2022)’

Modified the discussion:

‘No evidence of an association of being a member of a longitudinal follow-up study and studies conducted during follow-up to a use of psychiatric care services was found.’

Reviewer R3.3. Analyses all compare the full 1966 cohort to the combined 1965/67 cohort. However, the 1966 cohort actually diminishes over time, as reduced numbers take part at age 1, 14, 31, and 46. Can the authors compare the reduced samples to the comparison cohort to see if differences emerge over time? This again speaks to the fact that differences between participants and non-participants are typically interpreted as selection bias, rather than evidence for positive effects of the study's participation. e.g. The authors hypothesize that study participation will increase use of psychiatric services, so the 1966 cohort will use more that the 65/67 cohort. They find no evidence for this. Would their hypothesis apply to the samples reduced by attrition? i.e. if participation increases service use then would continued participation predict service use? This would run counter to a hypothesis that selection bias would mean that service use would predict drop out. Could the authors run such analyses to test these contrasting hypotheses?

Response R3.3. Our study group was not NFBC1966 per se, but a population born in 1966 in Northern Finland. We could not identify those in our study cohort who really participated in the NFBC1966 and took part in follow-up studies. Nevertheless, 96.3% of our study cohort were members of the NFBC1966.

We are aware of selective non-participation bias in the NFBC1966. It is already known that participants of the NFBC1966 in the 31-year and 46-year studies are more often female, were less often unemployed and are from higher social class (Nordström T, Miettunen J, Auvinen J, et al., 2021) and subjects with psychiatric disorders participated less actively than those without any psychiatric disorders in the 31-year study (Haapea M, Miettunen J, Läärä E, et al. 2008) We did not focus in the attrition of the NFBC1966 sample, but more in the effects of being a member in a longitudinal follow-up study, nevertheless have the subject participated in each follow-up study or not. As the postal follow-up questionnaires have been sent to N=11,768 original cohort members at 1-year follow-up, N=11,768 at 14-year follow-up, N=11,543 at 31-year follow-up and N=10,331 at age of 46-years, the vast majority of members of NFBC1966 have been aware of longitudinal follow-up.

We now have discussed the attrition and source of bias in the discussion section:

‘The participation rate in the follow-up studies decreased from 91.2% in the 1-year study, 93.6% in the 14-year study, 77.4% in the 31-year study to 66.5% in the 46-year study. It is already known that participants of the NFBC1966 in the 31-year and 46-year studies are more often female, were less often unemployed and are from higher social class [26] and subjects with psychiatric disorders participated less actively than those without any psychiatric disorders in the 31-year study [38]. The selective non-participation bias does exist in the NFBC1966. However, as the aim of the study was to examine the effects of participation in the longitudinal follow-up study, and the postal follow-up questionnaires have been sent to N=11,870 (97.0% of original cohort members) at 1-year follow-up, N=11,768 (96.2%) at 14-year follow-up, N=11,543 (94.4%) at 31-year follow-up and N=10,331 (83.8%) at age of 46-years, the vast majority of members of NFBC1966 have been aware of longitudinal follow-up.’

References:

Nordström T, Miettunen J, Auvinen J, Ala-Mursula L, Keinänen-Kiukaanniemi S, Veijola J, et al. Cohort Profile: 46 years of follow-up of the Northern Finland Birth Cohort 1966 (NFBC1966). Int J Epidemiol. 2021; dyab109. doi:10.1093/ije/dyab109

Haapea M, Miettunen J, Isohanni MK, Veijola JM, Läärä E, Järvelin MR, et al. Non-participation in a field survey with respect to psychiatric disorders. Scand J Public Health. 2008;36. doi:10.1177/1403494808092250

Attachment

Submitted filename: Response to reviewers.docx

Decision Letter 2

Silva Ibrahimi

22 Feb 2023

Association between participation in the Northern Finland Birth Cohort 1966 study and use of psychiatric care services

PONE-D-22-16407R2

Dear Dr. Kerkelae,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.Thank you for submitting your work with PLOS and the extraordinary work you introduced.

Please note that I have also acted as Rewier 2 of your submission.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Silva Ibrahimi, PhD

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #2: All comments have been addressed

Reviewer #4: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #2: Yes

Reviewer #4: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #2: Yes

Reviewer #4: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #2: No

Reviewer #4: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #2: Yes

Reviewer #4: (No Response)

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #2: I had already accepted the paper once before

Reviewer #4: The authors addressed all the previous comments raised in a very comprehensive and scientific approach. I congratulate them for the extraordinary work done in the cohort-study work and the technical strength given throughout the paper.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #2: No

Reviewer #4: No

**********

Acceptance letter

Silva Ibrahimi

24 Feb 2023

PONE-D-22-16407R2

Association between participation in the Northern Finland Birth Cohort 1966 study and use of psychiatric care services

Dear Dr. Kerkelae:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Silva Ibrahimi

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    Attachment

    Submitted filename: Response to Reviewers.docx

    Attachment

    Submitted filename: Response to reviewers.docx

    Data Availability Statement

    Data cannot be shared publicly because the utilised data have been given for this specific study (Permission numbers: TK-53-1053-19, VRK/3285/2019-2, THL/1254/2019), and the data cannot be shared without permission from the register keepers. The same data can be applied from Findata, the Finnish Health and Social Data Permit Authority by researchers who meet the criteria for access to confidential data. Additionally, Findata, can prepare statistical tables from the registers used in this study: https://findata.fi/en/permits/data-requests/.


    Articles from PLOS ONE are provided here courtesy of PLOS

    RESOURCES